| Last Price | Today's Change | 52-Week Range | Trading Volume |
|---|---|---|---|
| 6.33 | -0.08 (-1.25%) | 4.25 - 6.56 | 137.7 thousand (Below Avg) |
Market data as of 4:02PM 05/24/13. Quotes are delayed by at least 15 min.
| Open | 6.36 |
|---|---|
| Previous Close | 6.41 |
| Day's Range | 6.33 - 6.41 |
| Market Cap | 403.1M |
| Avg Volume (10 Day) | 238.4K |
| Price/Earnings (Trailing 12 Mo.) | -- |
| Earnings Per Share (Trailing 12 Mo.) | -0.28 |
| Dividend Yield | No Dividend |


These seven metrics are a snap to calculate, thanks to Quicken.com's One-Click Scorecard. Our goal with this tool is to help you evaluate potential investment candidates and eliminate those equities that aren't up to snuff. One-Click Scorecard won't do all the homework necessary for you to reach a decision, but it will help you develop a list of quality stocks to watch and study further.
| Performed well consistently? | Fail |
|---|---|
| Avoids excess debt? | Fail |
| Converting sales to profits? | Fail |
| Shareholder's money handled rationally? | Neutral |
| Increased shareholder value? | Neutral |
| Consistently increased owner earnings? | Fail |
| Sells at 25% discount to intrinsic value? | Fail |


These eight metrics are a snap to calculate, thanks to Quicken.com's One-Click Scorecard. Our goal with this tool is to help you evaluate potential investment candidates and eliminate those equities that aren't up to snuff. One-Click Scorecard won't do all the homework necessary for you to reach a decision, but it will help you develop a list of quality stocks to watch and study further.
| Pays a cash dividend? | Neutral |
|---|---|
| Room to increase dividends? | Fail |
| Increased earnings over time? | Neutral |
| Borrows within reasonable limits? | Pass |
| Stock is undervalued? | Fail |
| Have investors caught on? | Fail |
| Has support of institutional investors? | Fail |
| Has sufficient liquidity? | Pass |
Lifshitz Law Firm Announces Investigation of Buckeye Technologies Inc., Intuitive Surgical, Inc., MPG Office Trust, Inc., and PROLOR Biotech, Inc.
PR Newswire - Sunday 04/28/2013 2:15 PM ET
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of PROLOR Biotech, Inc. in Connection with the Sale of the Company to OPKO Health, Inc.
Business Wire - Friday 04/26/2013 4:06 PM ET
Rigrodsky & Long, P.A. Announces Investigation Of PROLOR Biotech, Inc. Buyout
Business Wire - Thursday 04/25/2013 9:35 PM ET
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of PROLOR Biotech, Inc. in Connection with the Sale of the Company to OPKO Health, Inc.
Business Wire - Thursday 04/25/2013 11:30 AM ET
Ryan & Maniskas, LLP Announces Investigation of PROLOR Biotech, Inc.
PR Newswire - Thursday 04/25/2013 10:56 AM ET
PROLOR Biotech Investor Alert by Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates PROLOR Biotech, Inc. Following Announcement of Acquisition by OPKO Health, Inc. for Potential Conflicts and Self Dealing
Business Wire - Wednesday 04/24/2013 9:17 PM ET
Acquisition of PROLOR Biotech, Inc. by OPKO Health, Inc. May Not Be in the Best Interests of PROLOR Shareholders
PR Newswire - Wednesday 04/24/2013 8:11 PM ET
Rigrodsky & Long, P.A. Announces Investigation Of PROLOR Biotech, Inc. Buyout
Business Wire - Wednesday 04/24/2013 7:15 PM ET
| PBTH | Industry Range | |
|---|---|---|
| Revenue Growth (1yr) | -- | |
| Net Income Growth (1yr) | -- | |
| Total Debt/Equity | 0.00 | |
| LT Debt/Equity | 0.00 | |
| Earnings Yield | -- | |
| Price/Sales | -- |
| Company | Last | Change |
|---|---|---|
| QLT Inc | 7.82 | -0.89% |
| Insmed Inc | 12.93 | +3.94% |
| NewLink Genetics Corp | 16.10 | +0.37% |
| Hyperion Therapeutics Inc | 21.15 | +3.02% |
| Cambrex Corp | 12.63 | +0.80% |
Data is delayed by at least 15 min.